Alzheimer’s patients divided into 5 subgroups, potentially enabling ‘personalized medicine,’ study finds

Researchers have discovered five new sub-groups among Alzheimer’s patients, according to a new study -- and different groups may require different treatment options.

"This may explain why some patients respond better to some treatments." Melissa Rudy is the health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com

"Previously, it was thought that Alzheimer's disease is one disease, and that treatments being developed will work similarly for all individuals," lead researcher Betty Tijms, associate professor of neuroscience and brain imaging at Amsterdam UMC, told Fox News Digital in an email.